HomeValneva shares slump after COVID vaccine deal with EU falls apartFILE PHOTO: Biotech firm Valneva works on an inactivated whole-virus

FILE PHOTO: Biotech firm Valneva works on an inactivated whole-virus

FILE PHOTO: The logo of French-Austrian biotech firm Valneva is seen outside their headquarters in Vienna, Austria, December 16, 2021. REUTERS/Lisi Niesner/File Photo
FILE PHOTO: Illustration shows Valneva’s logo
- Advertisment -
Google search engine

Most Read